Swiss National Bank Kura Oncology, Inc. Transaction History

Swiss National Bank

$150 Billion
Q3 2024

A detailed history of Swiss National Bank transactions in Kura Oncology, Inc. stock. As of the latest transaction made, Swiss National Bank holds 89,300 shares of KURA stock, worth $759,943. This represents 0.0% of its overall portfolio holdings.

Number of Shares

89,300

Previous 97,300 8.22%

Holding current value

$759,943

Previous $2 Million 12.93%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 07, 2024	SELL	$18.57 - $23.23 $148,560 - $185,840	-8,000 Reduced 8.22%	89,300 $1.74 Million
Q2 2024 Aug 08, 2024	SELL	$17.53 - $22.98 $89,403 - $117,198	-5,100 Reduced 4.98%	97,300 $2 Million
Q4 2023 Feb 06, 2024	SELL	$7.58 - $14.38 $149,326 - $283,286	-19,700 Reduced 16.13%	102,400 $1.47 Million
Q3 2023 Nov 08, 2023	BUY	$8.44 - $11.86 $66,676 - $93,694	7,900 Added 6.92%	122,100 $1.11 Million
Q2 2023 Aug 09, 2023	SELL	$9.62 - $13.99 $106,781 - $155,289	-11,100 Reduced 8.86%	114,200 $1.21 Million
Q1 2023 May 10, 2023	SELL	$10.71 - $14.6 $128,520 - $175,200	-12,000 Reduced 8.74%	125,300 $1.53 Million
Q4 2022 Feb 08, 2023	BUY	$11.23 - $16.9 $40,428 - $60,839	3,600 Added 2.69%	137,300 $1.7 Million
Q1 2022 May 09, 2022	BUY	$11.78 - $16.98 $113,088 - $163,008	9,600 Added 7.74%	133,700 $2.15 Million
Q2 2021 Aug 06, 2021	SELL	$20.85 - $29.88 $37,530 - $53,784	-1,800 Reduced 1.43%	124,100 $2.59 Million
Q1 2021 May 07, 2021	BUY	$24.75 - $39.14 $54,450 - $86,108	2,200 Added 1.78%	125,900 $3.56 Million
Q4 2020 Feb 05, 2021	BUY	$29.0 - $41.62 $368,300 - $528,574	12,700 Added 11.44%	123,700 $4.04 Million
Q3 2020 Nov 09, 2020	BUY	$16.3 - $30.64 $24,450 - $45,960	1,500 Added 1.37%	111,000 $3.4 Million
Q2 2020 Aug 05, 2020	BUY	$7.95 - $18.81 $346,620 - $820,116	43,600 Added 66.16%	109,500 $1.79 Million
Q1 2020 May 08, 2020	BUY	$6.45 - $14.04 $6,450 - $14,040	1,000 Added 1.54%	65,900 $656,000
Q4 2019 Feb 06, 2020	BUY	$12.97 - $15.94 $45,395 - $55,790	3,500 Added 5.7%	64,900 $892,000
Q2 2019 Aug 02, 2019	BUY	$14.71 - $19.79 $239,773 - $322,577	16,300 Added 36.14%	61,400 $1.21 Million
Q1 2019 May 10, 2019	BUY	$13.73 - $16.87 $39,817 - $48,923	2,900 Added 6.87%	45,100 $748,000
Q2 2018 Aug 09, 2018	BUY	$14.8 - $18.8 $624,560 - $793,360	42,200 New	42,200 $768,000

Others Institutions Holding KURA

# of Institutions

185

Shares Held

81.8M

Call Options Held

42.1K

Put Options Held

34K

View Full List

About Kura Oncology, Inc.

Ticker KURA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,893,000
Market Cap $569M
Description
Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...

More about KURA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

News

Stay updated on Swiss National Bank with notifications on news.

Account

Swiss National Bank Kura Oncology, Inc. Transaction History